Nrf2 signaling and redox homeostasis in the aging heart: A potential target to prevent cardiovascular diseases?

Ageing Research Reviews

Volumn 26, Issue , 2016, Pages 81-95

  Silva Palacios, Alejandro ^a,b   Königsberg, Mina ^b   Zazueta, Cecilia ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Aging; Cardiovascular system; Nrf2; Oxidative stress

Indexed keywords

ANTIOXIDANT; ARGINASE; ARGINASE II; C REACTIVE PROTEIN; CURCUMIN; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN; REACTIVE NITROGEN SPECIES; RESVERATROL; S6K1 PROTEIN; SULFORAPHANE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, HUMAN;

ADIPOCYTE; AGING; ARTERIAL STIFFNESS; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DENSITY; DETOXIFICATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FIBROBLAST; HEART; HEART FAILURE; HEART MUSCLE CELL; HEART OUTPUT; HEART PROTECTION; HEART SIZE; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HOMEOSTASIS; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; MITOCHONDRIAL MEMBRANE POTENTIAL; NITRATIVE STRESS; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; REDOX HOMEOSTASIS; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; AGED; ANTIOXIDANT RESPONSIVE ELEMENT; CARDIOVASCULAR DISEASES; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

AGED; AGING; ANTIOXIDANT RESPONSE ELEMENTS; CARDIOVASCULAR DISEASES; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84959339029     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.12.005     Document Type: Review

References (204)

1. Abdanipour A., Tiraihi T., Noori-Zadeh A., Majdi A., Gosaili R. Evaluation of lovastatin effects on expression of anti-apoptotic Nrf2 and PGC-1α genes in neural stem cells treated with hydrogen peroxide. Mol. Neurobiol. 2014, 49:1364-1372. http://dx.doi.org/10.1007/s12035-013-8613-5.
2. Ahmet I., Tae H.J., de Cabo R., Lakatta E.G., Talan M.I. Effects of calorie restriction on cardioprotection and cardiovascular health. J. Mol. Cell. Cardiol. 2011, 51:263-271. http://dx.doi.org/10.1016/j.yjmcc.2011.04.015.
3. Ahn Y.H., Hwang Y., Liu H., Wang X.J., Zhang Y., Stephenson K.K., Boronina T.N., Cole R.N., Dinkova-Kostova A.T., Talalay P., Cole P.A. Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9590-9595. http://dx.doi.org/10.1073/pnas.1004104107.
4. AlGhatrif M., Watts V.L., Niu X., Halushka M., Miller K.L., Vandegaer K., Bedja D., Fox-Talbot K., Bielawska A., Gabrielson K.L., Barouch L.A. Beneficial cardiac effects of caloric restriction are lost with age in a murine model of obesity. J. Cardiovasc. Transl. Res. 2013, 6:436-445. http://dx.doi.org/10.1007/s12265-013-9453-4.
5. Alam I., Ng T.P., Larbi A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediat. Inflamm. 2012, 2012:456456. http://dx.doi.org/10.1155/2012/456456.
6. Alarcón-Aguilar A., González-Puertos V.Y., Luna-López A., López-Macay A., Morán J., Santamaría A., Königsberg M. Comparing the effects of two neurotoxins in cortical astrocytes obtained from rats of different ages: involvement of oxidative damage. J. Appl. Toxicol. 2014, 34:127-138. http://.dx.doi.org/10.1002/jat.2841.
7. + toxicity after tBHQ pretreatmentary. Neurobiol. Aging 2014, 35:1901-1912. http://dx.doi.org/10.1016/j.neurobiolaging.2014.01.143.
8. Alfadda A.A., Benabdelkamel H., Masood A., Moustafa A., Sallam R., Bassas A., Duncan M. Proteomic analysis of mature adipocytes from obese patients in relation to aging. Exp. Gerontol. 2013, 48:1196-1203. http://dx.doi.org/10.1016/j.exger.2013.07.008.
9. Aronis A., Madar Z., Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774. 2 Macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic. Biol. Med. 2005, 38:1221-1230.
10. Arza P., Netti V., Perosi F., Cernadas G., Ochoa F., Magnani N., Evelson P., Zotta E., Fellet A., Balaszczuk A.M. Involvement of nitric oxide and caveolins in the age-associated functional and structural changes in a heart under osmotic stress. Biomed. Pharmacother. 2015, 69:380-387. http://dx.doi.org/10.1016/j.biopha.2014.12.026.
11. Asselin C., Ducharme A., Ntimbane T., Ruiz M., Fortier A., Guertin M.C., Lavoie J., Diaz A., Levy E., Tardif J.C., Des-Rosiers C. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure. Redox Biol. 2013, 2:148-155. http://.dx.doi.org/10.1016/j.redox.2013.12.009.
12. Böning A., Rohrbach S., Kohlhepp L., Heep M., Hagmüller S., Niemann B., Mühlfeld C. Differences in ischemic damage between young and old hearts-effects of blood cardioplegia. Exp. Gerontol. 2015, 67:3-8. http://dx.doi.org/10.1016/j.exger.2015.04.012.
13. Bailey-Downs L.C., Mitschelen M., Sosnowska D., Toth P., Pinto J.T., Ballabh P., Valcarcel-Ares M.N., Farley J., Koller A., Henthorn J.C., Bass C., Sonntag W.E., Ungvari Z., Csiszar A. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:313-329. http://dx.doi.org/10.1093/gerona/glr164.
14. Barquera S., Pedroza-Tobías A., Medina C., Hernández-Barrera L., Bibbins-Domingo K., Lozano R., Moran A.E. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch. Med. Res. 2015, 46:328-338. http://dx.doi.org/10.1016/j.arcmed.2015.06.006.
15. Bergmann O., Bharduraj R.D., Bernanrd S., Zdunek S., Bernabe-Herder F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Joringe S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102. http://dx.doi.org/10.1126/science.1164680.
16. Bhatia N.K., Srivastava A., Katyal N., Jain N., Khan M.A., Kundu B., Deep S. Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim. Biophys. Acta 2015, 1854:426-436. http://dx.doi.org/10.1016/j.bbapap.2015.01.014.
17. Bhimaraj A., Tang W.H. Role of oxidative stress in disease progression in stage B, a pre-cursor of heart failure. Heart Fail. Clin. 2012, 8:101-111. arxiv:/http//dx.doi.org/10.1016/j.hfc.2011.08.003.
18. Borlaug B.A., Redfield M.M., Melenovsky V., Kane G.C., Karon B.L., Jacobsen S.J., Rodeheffer R.J. Longitudinal changes in left ventricular stiffness: a community-based study. Circ. Heart Fail. 2013, 6:944-952. http://dx.doi.org/10.1161/circheartfailure.113.000383.
19. Boudina S. Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?. Curr. Pharm. Des. 2013, 19:5684-5694.
20. Bowers S.L., Baudino T.A. Cardiac myocyte-fibroblast interactions and the coronary vasculature. J. Cardiovasc. Transl. Res. 2012, 5:783-793. http://dx.doi.org/10.1007/s12265-012-9407-2.
21. Boyle J.J., Johns M., Lo J., Chiodini A., Ambrose N., Evans P.C., Mason J.C., Haskard D.O. Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2685-2691. http://dx.doi.org/10.1161/atvbaha.111.225813.
22. Buelna-Chontal M., Zazueta C. Redox activation of Nrf2 & NF-κB: a double end sword?. Cell Signal. 2013, 25:2548-2557. http://dx.doi.org/10.1016/j.cellsig.2013.08.007.
23. Buelna-Chontal M., Guevara-Chávez J.G., Silva-Palacios A., Medina-Campos O.N., Pedraza-Chaverri J., Zazueta C. Nrf2-regulated antioxidant response is activated by protein kinase C in postconditioned rat hearts. Free Radic. Biol. Med. 2014, 74:145-156. http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.021.
24. Bugger H., Abel E.D. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin. Sci. (Lond.) 2008, 114:195-210. http://dx.doi.org/10.1042/cs20070166.
25. Cabassi A., Binno S.M., Tedeschi S., Ruzicka V., Dancelli S., Rocco R., Vicini V., Coghi P., Regolisti G., Montanari A., Fiaccadori E., Govoni P., Piepoli M., de Champlain J. Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin. Circ. Res. 2014, 114:1723-1732. http://dx.doi.org/10.1161/circresaha.114.302849.
26. Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., Bates T.E., Giuffrida-Stella A.M., Schapira T., Dinkova-Kostova A.T., Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 2008, 33:2444-2471. http://dx.doi.org/10.1007/s11064-008-9775-9.
27. Canepa M., Strait J.B., Milaneschi Y., AlGhatrif M., Ramachandran R., Makrogiannis S., Moni M., David M., Brunelli C., Lakatta E.G., Ferrucci L. The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore longitudinal study of aging. Nutr. Metab. Cardiovasc. Dis. 2013, 23:1263-1270. http://dx.doi.org/10.1016/j.numecd.2013.04.003.
28. Carmona-Ramírez I., Santamaría A., Tobón-Velasco J.C., Orozco-Ibarra M., González-Herrera I.G., Pedraza-Chaverrí J., Maldonado P.D. Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J. Nutr. Biochem. 2013, 24:14-24. http://dx.doi.org/10.1016/j.jnutbio.2011.12.010.
29. Carreño J.E., Apablaza F., Ocaranza M.P., Jalil J.E. Cardiac hypertrophy: molecular and cellular events. Rev. Esp. Cardiol. 2006, 59:473-486.
30. Chan J.Y., Chan S.H. Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: a lesson learnt from DJ-1. Pharmacol. Ther. 2015, 156:69-74. http://dx.doi.org/10.1016/j.pharmthera.2015.09.005.
31. Chapple S.J., Siow R.C., Mann G.E. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int. J. Biochem. Cell Biol. 2012, 44:1315-1320. http://dx.doi.org/10.1016/j.biocel.2012.04.021.
32. Chen B., Lu Y., Chen Y., Cheng J. The role of Nrf2 in oxidative stress-induced endothelial injuries. J. Endocrinol. 2015, 225:R83-R99.
33. Chen-Scarabelli C., Hughes S.E., Landon G., Rowley P., Allebban Z., Lawson N., Saravolatz L., Gardin J., Latchman D., Scarabelli T.M. A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. Eur. J. Heart Fail. 2005, 7:927-930.
34. Cheng A.S., Cheng Y.H., Lee C.Y., Chung C.Y., Chang W.C. Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo. Nutrients 2015, 7:2850-2865. http://dx.doi.org/10.1530/JOE-14-0662.
35. Christoffersen C., Bollano E., Lindegaard M.L., Bartels E.D., Goetze J.P., Andersen C.B., Nielsen L.B. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003, 144:3483-3490.
36. Chung S.S., Vadgama J.V. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Anticancer Res. 2015, 35:39-46.
37. Colín-González A.L., Luna-López A., Königsberg M., Ali S.F., Pedraza-Chaverrí J., Santamaría A. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway. Neuroscience 2014, 260:130-139. http://dx.doi.org/10.1016/j.neuroscience.2013.12.025.
38. 2 production and oxidative damage. Cardiovasc. Res. 2007, 74:456-465.
39. Correa F., Buelna-Chontal M., Hernández-Reséndiz S., García-Niño W.R., Roldán J.F., Soto V., Silva-Palacios A., Amador A., Pedraza-Chaverrí J., Tapia E., Zazueta C. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic. Biol. Med. 2013, 61:119-129. http://dx.doi.org/10.1016/j.freeradbiomed.2013.03.017.
40. Csiszar A., Pacher P., Kaley G., Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol. 2005, 3:285-291.
41. Csiszar A., Sosnowska D., Wang M., Lakatta E.G., Sonntag W.E., Ungvari Z. Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:811-820. http://dx.doi.org/10.1093/gerona/glr228.
42. Csiszar A., Csiszar A., Pinto J.T., Gautam T., Kleusch C., Hoffmann B., Tucsek Z., Toth P., Sonntag W.E., Ungvari Z. Resveratrol encapsulated in novel fusogenic liposomes activates Nrf2 and attenuates oxidative stress in cerebromicrovascular endothelial cells from aged rats. J. Gerontol. A Biol. Sci. Med. Sci. 2015, 70:303-313. http://dx.doi.org/10.1093/gerona/glu029.
43. Dai D.F., Karunadharma P.P., Chiao Y.A., Basisty N., Crispin D., Hsieh E.J., Chen T., Gu H., Djukovic D., Raftery D., Beyer R.P., MacCoss M.J., Rabinovitch P.S. Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell 2014, 13:529-539. http://dx.doi.org/10.1111/acel.12203.
44. Das L., Vinayak M. Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS One 2015, 10:e0124000. http://dx.doi.org/10.1371/journal.pone.0124000.
45. De Meyer G.R., De Keulenaer G.W., Martinet W. Role of autophagy in heart failure associated with aging. Heart Fail. Rev. 2010, 15:423-430. http://dx.doi.org/10.1007/s10741-010-9166-6.
46. Deguchi A. Curcumin targets in inflammation and cancer. Endocr. Metab. Immune Disord. Drug Targets 2014, 15:88-96.
47. Dimmeler S., Nicotera P. MicroRNAs in age-related diseases. EMBO Mol. Med. 2013, 5:180-190. http://dx.doi.org/10.1002/emmm.201201986.
48. Dokken B.B. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 2008, 21:160-165.
49. Dominguez-Gerpe L., Araujo-Vilar D. Prematurely aged children: molecular alterations leading to Hutchinson-Gilford progeria and Werner syndromes. Curr. Aging Sci. 2008, 1:202-212.
50. Donato A.J., Eskurza I., Silver A.E., Levy A.S., Pierce G.l., Gates P.E., Seals D.R. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ. Res. 2007, 100:1659-1666.
51. Donato A.J., Morgan R.G., Walker A.E., Lesniewski L.A. Cellular and molecular biology of aging endothelial cells. J. Mol. Cell. Cardiol. 2015, 34-36. pii: S0022-2828(15). http://dx.doi.org/10.1016/j.yjmcc.2015.01.021.
52. Dower J.I., Geleijnse J.M., Gijsbers L., Zock P.L., Kromhout D., Hollman P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015, 101:914-921. http://.dx.doi.org/10.3945/ajcn.114.098590.
53. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton-Webb R., Lee M.E., Nabel G.J., Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 2001, 7:693-698.
54. Duicu O.M., Mirica S.N., Gheorgheosu D.E., Privistirescu A.I., Fira-Mladinescu O., Muntean D.M. Ageing induced decrease in cardiac mitochondrial function in healthy rats. Can. J. Physiol. Pharmacol. 2013, 91:593-600. http://dx.doi.org/10.1139/cjpp-2012-0422.
55. Dutta D., Xu J., Kim J.S., Dunn W.A., Leeuwenburgh C. Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity. Autophagy 2013, 9:328-344. http://dx.doi.org/10.4161/auto.22971.
56. Ebbing M., Bleie Ø., Ueland P.M., Nordrehaug J.E., Nilsen D.W., Vollset S.E., Refsum H., Pedersen E.K., Nygård Ø. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300:795-804. http://dx.doi.org/10.1001/jama.300.7.795.
57. Ebrahim Z., Yellon D.M., Baxter G.F. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp. Gerontol. 2007, 42:807-814.
58. El Assar M., Angulo J., Rodríguez-Mañas L. Oxidative stress and vascular inflammation in aging. Free Radic. Biol. Med. 2013, 65:380-401. http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.003.
59. Elavarasan J., Velusamy P., Ganesan T., Ramakrishnan S.K., Rajasekaran D., Periandavan K. Hesperidin-mediated expression of Nrf2 and upregulation of antioxidant status in senescent rat heart. J. Pharm. Pharmacol. 2012, 64:1472-1482. http://dx.doi.org/10.1111/j.2042-7158.2012.01512.x.
60. Fan Q., Chen M., Fang X., Lau W.B., Xue L., Zhao L., Zhang H., Liang Y.H., Bai X., Niu H.Y., Ye J., Chen Q., Yang X., Liu M. Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and ratsg might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats. Age (Dordr.) 2013, 35:1017-1026. http://dx.doi.org/10.1007/s11357-012-9421-y.
61. Feingold, K., Grunfeld, C., 2000-2015. Role of glucose and lipids in the cardiovascular disease of patients with diabetes. In: De Groot, L.J., Beck-Peccoz, P., Chrousos, G., Dungan, K., Grossman, A., Hershman, J.M., Koch, C., McLachlan, R., New, M., Rebar, R., Singer, F., Vinik, A., Weickert, M.O. (Eds), South Dartmouth (MA).
62. Fenton R.A., Dickson E.W., Meyer T.E., Dobson J.G. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 2000, 32:1371-1375.
63. Foncea R., Carvajal C., Almarza C., Leighton F. Endothelial cell oxidative stress and signal transduction. Biol. Res. 2000, 33:89-96.
64. Frank A., Bonney M., Bonney S., Weitzel L., Koeppen M., Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin. Cardiothorac. Vasc. Anesth. 2012, 16:123-132. http://dx.doi.org/10.1177/1089253211436350.
65. From A.M., Scott C.G., Chen H.H. Changes in diastolic dysfunction in diabetes mellitus over time. Am. J. Cardiol. 2009, 103:1463-1466. http://dx.doi.org/10.1016/j.amjcard.2009.01.358.
66. Fujita T., Uchida K., Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim. Biophys. Acta 1992, 1116:122-128.
67. Funayama R., Ishiwaka F. Cellular senescence and chromatin structure. Chromosome 2007, 116:431-440.
68. Galan P., Kesse-Guyot E., Czernichow S., Briancon S., Blacher J., Hercberg S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010, 341:c6273. http://dx.doi.org/10.1136/bmj.c6273.
69. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 2005, 115:500-508.
70. Givertz M.M., Anstrom K.J., Redfield M.M., Deswal A., Haddad H., Butler J., Tang W.H., Dunlap M.E., LeWinter M.M., Mann D.L., Felker G.M., O'Connor C.M., Goldsmith S.R., Ofili E.O., Saltzberg M.T., Margulies K.B., Cappola T.P., Konstam M.A., Semigran M.J., McNulty S.E., Lee K.L., Shah M.R., Hernandez A.F. Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study. Circulation 2015, 131:1763-1771. http://dx.doi.org/10.1161/circulationaha.114.014536.
71. Goldspink D.F., Burniston J.G., Tan L.B. Cardiomyocyte death and the ageing and failing heart. Exp. Physiol. 2003, 88:447-458.
72. Goldstein P., Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 2007, 32:37-43.
73. Gong P., Stewart D., Hu B., Li N., Cook J., Nel A., Alam J. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxid. Redox Signal. 2002, 4:249-257.
74. Gounder S.S., Kannan S., Devadoss D., Miller C.J., Whitehead K.J., Odelberg S.J., Firpo M.A., Paine R., Hoidal J.R., Abel E.D., Rajasekaran N.S. Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS One 2012, 7:e45697. http://dx.doi.org/10.1371/journal.pone.0045697.
75. Green J.B. Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox. Postgrad. Med. 2014, 126:190-204. http://dx.doi.org/10.3810/pgm.2014.05.2767.
76. Guarner V., Rubio-Ruiz M.E. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdiscip. Top. Gerontol. 2015, 40:99-106. http://dx.doi.org/10.1159/000364934.
77. Halter J.B., Musi N., McFarland-Horne F., Crandall J.P., Goldberg A., Harkless L., Hazzard W.R., Huang E.S., Kirkman M.S., Plutzky J., Schmader K.E., Zieman S., High K.P. Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes 2014, 63:2578-2589. http://dx.doi.org/10.2337/db14-0020.
78. Harith H.H., Morris M.J., Kavurma M.M. On the TRAIL of obesity and diabetes. Trends Endocrinol. Metab. 2013, 24:578-587. http://dx.doi.org/10.1016/j.tem.2013.07.001.
79. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
80. Harman D. The aging process. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:7124-7128.
81. Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013, 123:92-100. http://dx.doi.org/10.1172/jci62874.
82. Hees P.S., Fleg J.L., Lakatta E.G., Shapiro E.P. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am. J. Cardiol. 2002, 90:1231-1236.
83. Hernández-Reséndiz S., Roldán F.J., Correa F., Martínez-Abundis E., Osorio-Valencia G., Ruíz-de-Jesús O., Alexánderson-Rosas E., Vigueras R.M., Franco M., Zazueta C. Postconditioning protects against reperfusion injury in hypertensive dilated cardiomyopathy by activating MEK/ERK1/2 signaling. J. Card. Fail. 2013, 19:135-146. http://dx.doi.org/10.1016/j.cardfail.2013.01.003.
84. Hernández-Reséndiz S., Correa F., García-Niño W.R., Buelna-Chontal M., Roldán F.J., Ramírez-Camacho I., Delgado-Toral C., Carbó R., Pedraza-Chaverrí J., Tapia E., Zazueta C. Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease. Cardiovasc. Drugs Ther 2015, 29:111-120. http://dx.doi.org/10.1007/s10557-015-6581-x.
85. Hodgson J.M., Croft K.D., Woodman R.J., Puddey I.B., Bondonno C.P., Wu J.H., Beilin L.J., Lukoshkova E.V., Head G.A., Ward N.C. Effects of vitamin E, vitamin C and polyphenols on the rate of blood pressure variation: results of two randomised controlled trials. Br. J. Nutr. 2014, 112:1551-1561. http://dx.doi.org/10.1017/s0007114514002542.
86. Hosseini V.N. Comparison of coenzyme Q10 versus placebo in chronic heart failure. Res. J. Biol. Sci. 2008, 3:884-887. ISSN. 1815-8846.
87. Hsieh P.C., Segers V.F., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D., Robbins J., Lee R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 2007, 13:970-974.
88. Huang Y., Li W., Su Z.Y., Kong A.T. The complexity of the Nrf2 pathway: beyond the antioxidant response. J. Nutr. Biochem. 2015, 179-185. pii:S0955-2863. http://dx.doi.org/10.1016/j.jnutbio.2015.08.001.
89. Hummel S.L., Kitzman D.W. Update on heart failure with preserved ejection fraction. Curr. Cardiovasc. Risk Rep. 2013, 7:495-502.
90. Hwang E., Yoon G., Kang H. A comparative analysis of the cell biology of senescence and aging. Cell. Mol. Life Sci. 2009, 66:2503-2524. http://dx.doi.org/10.1007/s00018-009-0034-2.
91. Intapad S., Tull F.L., Brown A.D., Dasinger J.H., Ojeda N.B., Fahling J.M., Alexander B.T. Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age. Hypertension 2013, 61:828-834. http://dx.doi.org/10.1161/hypertensionaha.111.00645.
92. Ishikawa K., Sugawara D., Wang Xp., Suzuki K., Itabe H., Maruyama Y., Lusis A.J. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ. Res. 2001, 88:506-512.
93. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-delta(12,14)-prostaglandin J(2). Mol. Cell Biol. 2004, 24:36-45.
94. Jannin B., Menzel M., Berlot J.P., Delmas D., Lancon A., Latruffe N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem. Pharmacol. 2004, 68:1113-1118.
95. Jay D., Hitomi H., Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 2006, 40:183-192.
96. Jyrkkänen H.K., Kansanen E., Inkala M., Kivelä A.M., Hurttila H., Heinonen S.E., Goldsteins G., Jauhiainen S., Tiainen S., Makkonen H., Oskolkova O., Afonyushkin T., Koistinaho J., Yamamoto M., Bochkov V.N., Ylä-Herttuala S., Levonen A.L. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circ. Res. 2008, 103:e1-e9. http://dx.doi.org/10.1161/circresaha.108.176883.
97. Königsberg, M., 2008. Radicales Libres y Estrés Oxidativo: Aplicaciones Médicas. In: Moderno, (), México.
98. Kannan S., Muthusamy V.R., Whitehead K.J., Wang L., Gomes A.V., Litwin S.E., Kensler T.W., Abel E.D., Hoidal J.R., Rajasekaran N.S. Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy. Cardiovasc. Res. 2013, 100:63-73. http://dx.doi.org/10.1093/cvr/cvt150.
99. Kensler T.W., Egner P.A., Agyeman A.S., Visvanathan K., Groopman J.D., Chen J.G., Chen T.Y., Fahey J.W., Talalay P. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top. Curr. Chem. 2013, 329:163-177. http://dx.doi.org/10.1007/128_2012_339.
100. Kim J.H., Bugaj L.J., Oh Y.J., Bivalacqua T.J., Ryoo S., Soucy K.G., Santhanam L., Webb A., Camara A., Sikka G., Nyhan D., Shoukas A.A., Ilies M., Christianson D.W., Champion H.C., Berkowitz D.E. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 1985, 107:1249-1257. http://dx.doi.org/10.1152/japplphysiol.91393.2008.
101. Kirkwood T.B. Comparative life spans of species: why do species have the life spans they do?. Am. J. Clin. Nutr. 1992, 55:1191S-1195S.
102. Kuhlow D., Florian S., von Figura G., Weimer S., Schulz N., Petzke K.J., Zarse K., Pfeiffer A.F., Rudolph K.L., Ristow M. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging (Albany NY) 2010, 2:650-658.
103. Kwak H.B. Aging, exercise, and extracellular matrix in the heart. J. Exerc. Rehabil. 2013, 9:338-347. http://dx.doi.org/10.12965/jer.130049.
104. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217. http://dx.doi.org/10.1016/j.cell.2013.05.039.
105. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
106. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's health study: a randomized controlled trial. JAMA 2005, 294:56-65.
107. Lee M.Y., Wang Y., Vanhoutte P.M. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFκB. J. Vasc. Res. 2010, 47:287-298. http://dx.doi.org/10.1159/000265563.
108. Li D., Qu Y., Tao L., Liu H., Hu A., Gao F., Sharifi-Azad S., Grunwald Z., Ma X.L., Sun J.Z. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J. Surg. Res. 2006, 131:64-72.
109. Li J., Ichikawa T., Villacorta L., Janicki J.S., Brower G.L., Yamamoto M., Cui T. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1843-1850. http://dx.doi.org/10.1161/atvbaha.109.189480.
110. Li J., Zhang C., Xing Y., Janicki J.S., Yamamoto M., Wang X.L., Tang D.Q., Cui T. Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy. Cardiovasc. Res. 2011, 90:315-324. http://dx.doi.org/10.1093/cvr/cvr010.
111. Lin H., Li H.F., Chen H.H., Lai P.F., Juan S.H., Chen J.J., Cheng C.F. Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule beclin-1 pathway. Mol. Pharmacol. 2014, 85:682-691. http://dx.doi.org/10.1124/mol.113.090092.
112. Lopes R.A., Neves K.B., Tostes R.C., Montezano A.C., Touyz R.M. Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension 2015, 66:1240-1250. http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06163.
113. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 1995, 38:87-104.
114. Lucas D.T., Szweda L.I. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:510-514.
115. Macheret F., Bartz T.M., Djousse L., Ix J.H., Mukamal K.J., Zieman S.J., Siscovick D.S., Tracy R.P., Heckbert S.R., Psaty B.M., Kizer J.R. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart 2015, 101:1368-1374. http://dx.doi.org/10.1136/heartjnl-2014-307015.
116. Manea A., Manea S.A., Gafencu A.V., Raicu M. Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells. Arch. Physiol. Biochem. 2007, 113:163-172.
117. Marín-García J. Cellular and molecular events in ischemic preconditioning: potential therapeutic applications in cardioprotection. Future Cardiol. 2005, 1:111-122. http://dx.doi.org/10.1517/14796678.1.1.111.
118. Mariani J., Ou R., Bailey M., Rowland M., Nagley P., Rosenfeldt F., Pepe S. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J. Thorac. Cardiovasc. Surg. 2000, 120:660-667.
119. Marquardt J.U., Gomez-Quiroz L., Arreguin-Camacho L.O., Pinna F., Lee Y.H., Kitade M., Domínguez M.P., Castven D., Breuhahn K., Conner E.A., Galle P.R., Andersen J.B., Factor V.M., Thorgeirsson S.S. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J. Hepatol. 2015, 63:661-669. http://dx.doi.org/10.1016/j.jhep.2015.04.018.
120. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Böhm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M.A., Jaarsma T., Køber L., Lip G.Y., Maggioni A.P., Parkhomenko A., Pieske B.M., Popescu B.A., Rønnevik P.K., Rutten F.H., Schwitter J., Seferovic P., Stepinska J., Trindade P.T., Voors A.A., Zannad F., Zeiher A., ESC Committee for Practice Guidelines ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2012, 33:1787-1847. http://dx.doi.org/10.1093/eurheartj/ehs104.
121. Meyer T.E., Kovács S.J., Ehsani A.A., Klein S., Holloszy J.O., Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 2006, 47:398-402.
122. Miao X., Bai Y., Sun W., Cui W., Xin Y., Wang Y., Tan Y., Miao L., Fu Y., Su G., Cai L. Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutr. Metab. (Lond.) 2012, 9:84. http://dx.doi.org/10.1186/1743-7075-9-84.
123. Michalakeas C.A., Parissis J.T., Douzenis A., Nikolaou M., Varounis C., Andreadou I., Antonellos N., Markantonis-Kiroudis S., Paraskevaidis I., Ikonomidis I., Lykouras E., Kremastinos D. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study. J. Card. Fail. 2011, 17:748-754. http://dx.doi.org/10.1016/j.cardfail.2011.05.004.
124. Michaud M., Balardy L., Moulis G., Gaudin C., Peyrot C., Vellas B., Cesari M., Nourhashemi F. Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc. 2013, 14:877-882. http://dx.doi.org/10.1016/j.jamda.2013.05.009.
125. Misaka T., Suzuki S., Miyata M., Kobayashi A., Ishigami A., Shishido T., Saitoh S., Kubota I., Takeishi Y. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction. Biochem. Biophys. Res. Commun. 2013, 439:142-147. http://dx.doi.org/10.1016/j.bbrc.2013.08.002.
126. Misaka T., Suzuki S., Miyata M., Kobayashi A., Shishido T., Ishigami A., Saitoh S., Hirose M., Kubota I., Takeishi Y. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling. Cardiovasc. Res. 2013, 99:461-470. http://dx.doi.org/10.1093/cvr/cvt122.
127. Montalescot G., Sechtem U., Achenbach S., Andreotti F., Arden C., Budaj A., Bugiardini R., Crea F., Cuisset T., Di Mario C., Ferreira J.R., Gersh B.J., Gitt A.K., Hulot J.S., Marx N., Opie L.H., Pfisterer M., Prescott E., Ruschitzka F., Sabaté M., Senior R., Taggart D.P., van der Wall E.E., Vrints C.J., ESC Committee for Practice Guidelines ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013, 34:2949-3003. http://dx.doi.org/10.1093/eurheartj/eht296.
128. Mortensen S.A., Rosenfeldt F., Kumar A., Dolliner P., Filipiak K.J., Pella D., Alehagen U., Steurer G., Littarru G.P. Q-SYMBIO study investigators. the effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014, 2:641-649. http://dx.doi.org/10.1016/j.jchf.2014.06.008.
129. Mozaffari M.S., Liu J.Y., Abebe W., Baban B. Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am. J. Cardiovasc. Dis. 2013, 3:180-196.
130. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
131. Narayanan S.V., Dave K.R., Saul I., Perez-Pinzon M.A. Resveratrol preconditioning protects against cerebral ischemic injury via nuclear erythroid 2-related factor 2. Stroke 2015, 46:1626-1632. http://dx.doi.org/10.1161/STROKEAHA.115.008921.
132. Neuhof C., Neuhof H. Calpain system and its involvement in myocardial ischemia and reperfusion injury. World J. Cardiol. 2014, 6:638-652. http://dx.doi.org/10.4330/wjc.v6.i7.638.
133. Niemann B., Chen Y., Teschner M., Li L., Silber R.E., Rohrbach S. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J. Am. Coll. Cardiol. 2011, 57:577-585. http://dx.doi.org/10.1016/j.jacc.2010.09.040.
134. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., Falcone S., Valerio A., Cantoni O., Clementi E., Moncada S., Carruba M.O. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
135. North B.J., Sinclair D.A. The intersection between aging and cardiovascular disease. Circ. Res. 2012, 110:1097-1108. http://dx.doi.org/10.1161/circresaha.111.246876.
136. Oelze M., Kröller-Schön S., Steven S., Lubos E., Doppler C., Hausding M., Tobias S., Brochhausen C., Li H., Torzewski M., Wenzel P., Bachschmid M., Lackner K.J., Schulz E., Münzel T., Daiber A. Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in aging. Hypertension 2014, 63:390-396. http://dx.doi.org/10.1161/hypertensionaha.113.01602.
137. Orongo A.M., Gustafsson A.B. Cell death in the myocardium: my heart won't go on. IUBMB Life 2013, 65:651-656. http://dx.doi.org/10.1002/iub.1180.
138. Pérez-Rojas J.M., Guerrero-Beltrán C.E., Cruz C., Sánchez-González D.J., Martínez-Martínez C.M., Pedraza-Chaverri J. Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats. Food Chem. Toxicol. 2011, 49:2631-2637. http://dx.doi.org/10.1016/j.fct.2011.07.008.
139. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., Griffith D., Griffor M., Loulakis P., Pabst B., Qiu X., Stockman B., Thanabal V., Varghese A., Ward J., Withka J., Ahn K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 2010, 285:8340-8351. http://dx.doi.org/10.1074/jbc.m109.088682.
140. Paulus W.J., Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 2013, 62:263-271. http://dx.doi.org/10.1016/j.jacc.2013.02.092.
141. Peart J.N., Pepe S., Reichelt M.E., Beckett N., See Hoe L., Ozberk V., Niesman I.R., Patel H.H., Headrick J.P. Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium. Exp. Gerontol. 2014, 50:72-81. http://dx.doi.org/10.1016/j.exger.2013.11.015.
142. Porter G.A., Urciuoli W.R., Brookes P.S., Nadtochiy S.M. SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1602-H1609. http://dx.doi.org/10.1152/ajpheart.00027.2014.
143. Poulose N., Raju R. Aging and injury: alterations in cellular energetics and organ function. Aging Dis. 2014, 5:101-108. http://dx.doi.org/10.14336/AD.2014.0500101.
144. Pu Y., Zhang H., Wang P., Zhao Y., Li Q., Wei X., Cui Y., Sun J., Shang Q., Liu D., Zhu Z. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell. Physiol. Biochem. 2013, 32:1167-1177. http://dx.doi.org/10.1159/000354516.
145. Qiu M., Shen W., Song X., Ju L., Tong W., Wang H., Zheng S., Jin Y., Wu Y., Wang W., Tian J. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study. Hypertension 2015, 65:525-530. http://dx.doi.org/10.1161/hypertensionaha.114.04632.
146. Rajapakse A.G., Yepuri G., Carvas J.M., Stein S., Matter C.M., Scerri I., Ruffieux J., Montani J.P., Ming X.F., Yang Z. Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS One 2011, 6:e19237. http://dx.doi.org/10.1371/journal.pone.0019237.
147. Rajasekaran N.S., Varadharaj S., Khanderao G.D., Davidson C.J., Kannan S., Firpo M.A., Zweier J.L., Benjamin I.J. Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxid. Redox Signal. 2011, 14:957-971. http://dx.doi.org/10.1089/ars.2010.3587.
148. Rajesh M., Mukhopadhyay P., Bátkai S., Patel V., Saito K., Matsumoto S., Kashiwaya Y., Horváth B., Mukhopadhyay B., Becker L., Haskó G., Liaudet L., Wink D.A., Veves A., Mechoulam R., Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2010, 56:2115-2125. http://dx.doi.org/10.1016/j.jacc.2010.07.033.
149. Rupérez A.I., Gil A., Aguilera C.M. Genetics of oxidative stress in obesity. Int. J. Mol. Sci. 2014, 15:3118-3144. http://dx.doi.org/10.3390/ijms15023118.
150. Russo M.A., Sansone L., Carnevale I., Limana F., Runci A., Polletta L., Perrone G.A., De Santis E., Tafani M. One special question to start with: can HIF/NFκB be a target in inflammation?. Endocr. Metab. Immune Disord. Drug Targets 2015, 15:171-185.
151. Ryter S.W., Otterbein L.E., Morse D., Choi A.M. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell Biochem. 2002, 234-235:249-263.
152. Sacerdoti D., Mania D., Pesce P., Gaiani S., Gatta A., Bolognesi M. Role of HO/CO in the control of peripheral circulation in humans. Int. J. Hypertens. 2012, 2012:236180. http://dx.doi.org/10.1155/2012/236180.
153. Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 1997, 59:551-571.
154. Safdar A., deBeer J., Tarnopolsky M.A. Dysfunctional Nrf2-Keap1 redox signaling in skeletal muscle of the sedentary old. Free Radic. Biol. Med. 2010, 49:1487-1493. http://dx.doi.org/10.1016/j.freeradbiomed.2010.08.010.
155. Schiborr C., Schwamm D., Kocher A., Rimbach G., Eckert G.P., Frank J. The senescence-accelerated mouse-prone 8 is not a suitable model for the investigation of cardiac inflammation and oxidative stress and their modulation by dietary phytochemicals. Pharmacol. Res. 2013, 74:113-120. http://dx.doi.org/10.1016/j.phrs.2013.06.004.
156. Scolletta S., Biagioli B. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure. Biomed. Pharmacother. 2010, 64:203-207. http://dx.doi.org/10.1016/j.biopha.2009.10.002.
157. Shinmura K. Effects of caloric restriction on cardiac oxidative stress and mitochondrial bioenergetics: potential role of cardiac sirtuins. Oxid. Med. Cell. Longev. 2013, 2013:528935. http://dx.doi.org/10.1155/2013/528935.
158. Shioi T., Inuzuka Y. Aging as a substrate of heart failure. J. Cardiol. 2012, 60:423-428. http://dx.doi.org/10.1016/j.jjcc.2012.07.015.
159. Shub C., Klein A.L., Zachariah P.K., Bailey K.R., Tajik A.J. Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin. Proc. 1994, 69:205-211.
160. Singh A., Steadman C.D., McCann G.P. Advances in the understanding of the pathophysiology and management of aortic stenosis: role of novel imaging techniques. Can. J. Cardiol. 2014, 30:994-1003. http://dx.doi.org/10.1016/j.cjca.2014.03.008.
161. Smyrnias I., Zhang X., Zhang M., Murray T.V., Brandes R.P., Schröder K., Brewer A.C., Shah A.M. Nicotinamide adenine dinucleotide phosphate oxidase-4-dependent upregulation of nuclear factor erythroid-derived 2-like 2 protects the heart during chronic pressure overload. Hypertension 2015, 65:547-553. http://dx.doi.org/10.1161/hypertensionaha.114.04208.
162. Stadler K. Peroxynitrite-driven mechanisms in diabetes and insulin resistance-the latest advances. Curr. Med. Chem. 2011, 18:280-290.
163. Strait J.B., Lakatta E.G. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail. Clin. 2012, 8:143-164. http://dx.doi.org/10.1016/j.hfc.2011.08.011.
164. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., Hagen T.M. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3381-3386.
165. Sun Z. Aging, arterial stiffness, and hypertension. Hypertension 2015, 65:252-256. http://dx.doi.org/10.1161/hypertensionaha.114.03617.
166. Sunagawa T., Shimizu T., Matsumoto A., Tagashira M., Kanda T., Shirasawa T., Nakaya H. Cardiac electrophysiological alterations in heart/muscle-specific manganese-superoxide dismutase-deficient mice: prevention by a dietary antioxidant polyphenol. Biomed. Res. Int. 2014, 2014:704291. http://dx.doi.org/10.1155/2014/704291.
167. Sung M.M., Dyck J.R. Age-related cardiovascular disease and the beneficial effects of calorie restriction. Heart Fail. Rev. 2012, 17:707-719. http://dx.doi.org/10.1007/s10741-011-9293-8.
168. Tamura S., Takahashi M., Kawamura S., Ishihara T. Basophilic degeneration of the myocardium: histological, immunohistochemical and immuno-electronmicroscopic studies. Histopathology 1995, 26:501-508.
169. Tanno M., Kuno A., Yano T., Miura T., Hisahara S., Ishikawa S., Shimamoto K., Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285:8375-8382. http://dx.doi.org/10.1074/jbc.m109.090266.
170. Tapia E., Soto V., Ortiz-Vega K.M., Zarco-Márquez G., Molina-Jijón E., Cristóbal-García M., Santamaría J., García-Niño W.R., Correa F., Zazueta C., Pedraza-Chaverri J. Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid. Med. Cell. Longev. 2012, 2012. 269039. http://dx.doi.org/10.1155/2012/269039.
171. Tasset I., Pérez-De La Cruz V., Elinos-Calderón D., Carrillo-Mora P., González-Herrera I.G., Luna-López A., Konigsberg M., Pedraza-Chaverrí J., Maldonado P.D., Ali S.F., Túnez I., Santamaría A. Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway. Neurosignals 2010, 18:24-31. http://dx.doi.org/10.1159/000243650.
172. Tatlidede E., Sehirli O., Velioğlu-Oğünc A., Cetinel S., Yeğen B.C., Yarat A., Süleymanoğlu S., Sener G. Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radic. Res. 2009, 43:195-205. http://dx.doi.org/10.1080/10715760802673008.
173. Townsend B.E., Chen Y.J., Jeffery E.H., Johnson R.W. Dietary broccoli mildly improves neuroinflammation in aged mice but does not reduce lipopolysaccharide-induced sickness behavior. Nutr. Res. 2014, 34:990-999. http://dx.doi.org/10.1016/j.nutres.2014.10.001.
174. Tsutsui M., Shimokawa H., Otsuji Y., Yanagihara N. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol. Ther. 2010, 128:499-508. http://dx.doi.org/10.1016/j.pharmthera.2010.08.010.
175. Tung B.T., Rodriguez-Bies E., Thanh H.N., Le-Thi-Thu H., Navas P., Sanchez V.M., López-Lluch G. Organ and tissue-dependent effect of resveratrol and exercise on antioxidant defenses of old mice. Aging Clin. Exp. Res. 2015, 27:775-783. http://dx.doi.org/10.1007/s40520-015-0366-8.
176. Ungvari Z., Bailey-Downs L., Sosnowska D., Gautam T., Koncz P., Losonczy G., Ballabh P., de Cabo R., Sonntag W.E., Csiszar A. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response. Am. J. Physiol. Heart. Circ. Physiol. 2011, 301:H363-H372. http://dx.doi.org/10.1152/ajpheart.01134.2010.
177. Uruno A., Furusawa Y., Yagishita Y., Fukutomi T., Muramatsu H., Negishi T., Sugawara A., Kensler T.W., Yamamoto M. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell Biol. 2013, 33:2996-3010. http://dx.doi.org/10.1128/MCB.00225-13.
178. Uruno A., Yagishita Y., Yamamoto M. The Keap1-Nrf2 system and diabetes mellitus. Arch. Biochem. Biophys. 2015, 566:76-84. http://dx.doi.org/10.1016/j.abb.2014.12.012.
179. Varga Z.V., Giricz Z., Liaudet L., Haskó G., Ferdinandy P., Pacher P. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim. Biophys. Acta 2015, 1852:232-242. http://dx.doi.org/10.1016/j.bbadis.2014.06.030.
180. Venkataraman K., Khurana S., Tai T. Oxidative stress in aging-matters of the heart and mind. Int. J. Mol. Sci. 2013, 14:17897-17925. http://dx.doi.org/10.3390/ijms140917897.
181. Walker A.E., Kaplon R.E., Lucking S.M., Russell-Nowlan M.J., Eckel R.H., Seals D.R. Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults. Hypertension 2012, 60:1517-1523. http://dx.doi.org/10.1161/hypertensionaha.112.203661.
182. Walters A.M., Porter G.A., Brookes P.S. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 2012, 111:1222-1236. http://dx.doi.org/10.1161/circresaha.112.265660.
183. Wang M., Zhang J., Walker S.J., Dworakowski R., Lakatta E.G., Shah A.M. Involvement of NADPH oxidase in age-associated cardiac remodeling. J. Mol. Cell. Cardiol. 2010, 48:765-772. http://dx.doi.org/10.1016/j.yjmcc.2010.01.006.
184. Wang Y., Lau W.B., Gao E., Tao L., Yuan Y., Li R., Wang X., Koch W.J., Ma X.L. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E663-E670. http://dx.doi.org/10.1152/ajpendo.00663.2009.
185. Wang H., Yang Y.J., Qian H.Y., Zhang Q., Xu H., Li J.J. Resveratrol in cardiovascular disease: what is known from current research?. Heart Fail. Rev. 2012, 17:437-448. http://dx.doi.org/10.1007/s10741-011-9260-4.
186. Wang M., Zhang J., Telljohann R., Jiang L., Wu J., Monticone R.E., Kapoor K., Talan M., Lakatta E.G. Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure. Hypertension 2012, 60:459-466. http://dx.doi.org/10.1161/hypertensionaha.112.191270.
187. Wannamethee S.G., Shaper A.G., Whincup P.H., Lennon L., Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch. Intern. Med. 2011, 171:404-410. http://dx.doi.org/10.1001/archinternmed.2011.2.
188. Wannamethee S.G., Bruckdorfer K.R., Shaper A.G., Papacosta O., Lennon L., Whincup P.H. Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men. Circ. Heart Fail. 2013, 6:647-654. http://dx.doi.org/10.1161/circheartfailure.112.000281.
189. Wessler J.D., Maurer M.S., Hummel S.L. Evaluating the safety and efficacy of sodium-restricted/dietary approaches to stop hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the geriatric out of hospital randomized meal trial in heart failure (GOURMET-HF). Am. Heart J. 2015, 169:342-348. e4. http://dx.doi.org/10.1016/j.ahj.2014.11.021.
190. Wheeler H., Kim H. Genetics and genomics of human ageing. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366:43-50. http://dx.doi.org/10.1098/rstb.2010.0259.
191. Willis M.S., Townley-Tilson W.H., Kang E.Y., Homeister J.W., Patterson C. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ. Res. 2010, 106:463-478. http://dx.doi.org/10.1161/circresaha.109.208801.
192. Wohlfahrt P., Redfield M.M., Lopez-Jimenez F., Melenovsky V., Kane G.C., Rodeheffer R.J., Borlaug B.A. Impact of general and central adiposity on ventricular-arterial aging in women and men. JACC Heart Fail. 2014, 2:489-499. http://dx.doi.org/10.1016/j.jchf.2014.03.014.
193. Wojda A., Witt M. Manifestations of aging at the cytogenetic level. J. Appl. Genet. 2003, 44:383-399.
194. Wojtovich A.P., Nadtochiy S.M., Brookes P.S., Nehrke K. Ischemic preconditioning: the role of mitochondria and aging. Exp. Gerontol. 2012, 47:1-7. http://dx.doi.org/10.1016/j.exger.2011.11.001.
195. Wu C.C., Huang Y.S., Chen J.S., Huang C.F., Su S.L., Lu K.C., Lin Y.F., Chu P., Lin S.H., Sytwu H.K. Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy. PLoS One 2015, 10:e0125726. http://dx.doi.org/10.1371/journal.pone.0125726.
196. Xu J., Kulkarni S.R., Donepudi A.C., More V.R., Slitt A.L. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice. Diabetes 2012, 61:3208-3218. http://dx.doi.org/10.2337/db11-1716.
197. Yamazaki H., Tanji K., Wakabayashi K., Matsuura S., Itoh K. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases. Pathol. Int. 2015, 65:210-219. http://dx.doi.org/10.1111/pin.12261.
198. Yeh C.C., Su Y.H., Lin Y.J., Chen P.J., Shi C.S., Chen C.N., Chang H.I. Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis. Drug Des. Dev. Ther. 2015, 9:2285-2300. http://dx.doi.org/10.2147/DDDT.S78277.
199. Yepuri G., Velagapudi S., Xiong Y., Rajapakse A.G., Montani J.P., Ming X.F., Yang Z. Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging. Aging Cell 2012, 11:1005-1016. http://dx.doi.org/10.1111/acel.12001.
200. Yin K., Zhao L., Feng D., Ma W., Liu Y., Wang Y., Liang J., Yang F., Bi C., Chen H., Li X., Lu Y., Cai B. Resveratrol attenuated low ambient temperature-induced myocardial hypertrophy via inhibiting cardiomyocyte apoptosis. Cell. Physiol. Biochem. 2015, 35:2451-2462. http://dx.doi.org/10.1159/000374045.
201. Zhou Q., Li L., Zhao B., Guan K.L. The hippo pathway in heart development, regeneration, and diseases. Circ. Res. 2015, 116:1431-1447. http://dx.doi.org/10.1161/circresaha.116.303311.
202. Zweier J.L., Talukder M.A. The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 2006, 70:181-190.
203. de Vries J.E., Vork M.M., Roemen T.H., de Jong Y.F., Cleutjens J.P., van der Vusse G.J., van Bilsen M. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J. Lipid Res. 1997, 38:1384-1394.
204. van Dijk S.C., Enneman A.W., Swart K.M., van Wijngaarden J.P., Ham A.C., Brouwer-Brolsma E.M., van der Zwaluw N.L., Blom H.J., Feskens E.J., Geleijnse J.M., van Schoor N.M., Dhonukshe-Rutten R.A., de Jongh R.T., Lips P., de Groot L.C., Uitterlinden A.G., Smulders Y.M., van den Meiracker A.H., Mattace Raso F.U., van der Velde N. Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial. J. Hypertens. 2015, 33:1897-1906. http://dx.doi.org/10.1097/HJH.0000000000000647.